Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-22 Sale | 2026-01-22 8:09 pm | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 3,500,000 | $36.4 | $127,400,000 | 5,570,832 (Indirect) | View |
| 2026-01-22 Sale | 2026-01-22 8:07 pm | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 1,750,000 | $76.3 | $133,525,000 | 7,144,300 (Indirect) | View |
| 2025-12-04 Purchase | 2025-12-08 4:30 pm | CRESCENT BIOPHARMA INC. | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 1,360,000 | $13.41 | $18,237,600 | 4,516,006 (Indirect) | View |
| 2025-10-23 Purchase | 2025-10-27 4:30 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 454,545 | $22 | $9,999,990 | 3,914,458 (Indirect) | View |
| 2025-10-07 Purchase | 2025-10-09 4:15 pm | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 316,219 | $19 | $6,008,161 | 2,209,025 (Indirect) | View |
| 2025-07-10 Purchase | 2025-07-14 4:30 pm | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 2,777,777 | $9 | $24,999,993 | 9,003,418 (Indirect) | View |
| 2024-09-13 Purchase | 2024-09-17 9:00 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 1,600,000 | $18.75 | $30,000,000 | 3,445,813 (Indirect) | View |
| 2024-09-16 Purchase(A) | 2024-09-17 8:56 pm | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 300,000 | $17 | $5,100,000 | 1,929,806 (Indirect) | View |
| 2024-09-16 Purchase | 2024-09-16 8:54 pm | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 300,000 | $17 | $5,100,000 | 1,641,891 (Indirect) | View |
| 2024-01-22 Purchase | 2024-01-24 6:44 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner | 476,190 | $21 | $9,999,990 | 1,845,813 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-11-17 9:48 pm | N/A N/A | Galecto Inc. | GLTO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest V L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 26,801,000 (Indirect) | View |
| 2025-10-06 Option Award | 2025-10-08 4:15 pm | N/A N/A | Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest IV L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 855,047 | $9.1399 | 5,408,541 (Indirect) | View |
| 2025-10-06 Option Award | 2025-10-08 4:15 pm | N/A N/A | Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest IV L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 1,333,126 | $9.14 | 5,408,541 (Indirect) | View |
| 2025-09-17 Option Award | 2025-09-19 5:33 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 333,340 | $15 | 3,705,262 (Indirect) | View |
| 2025-06-23 Option Award | 2025-06-23 6:48 pm | N/A 2035-06-23 | GLYCOMIMETICS INC | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 9,023 | $0 | 9,023 (Indirect) | View |
Ownership | 2025-06-23 6:25 pm | N/A N/A | GLYCOMIMETICS INC | CBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 5,914,572 (Indirect) | View |
| 2025-06-17 Option Award | 2025-06-20 8:06 pm | N/A 2035-06-17 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director | 28,922 | $0 | 28,922 (Indirect) | View |
| 2025-06-10 Option Award | 2025-06-12 4:34 pm | N/A 2035-06-10 | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 18,500 | $0 | 18,500 (Indirect) | View |
| 2025-06-09 Exercise | 2025-06-11 5:00 pm | N/A 2025-06-10 | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 14,100 | $0 | 3,459,913 (Indirect) | View |
| 2025-06-09 Exercise | 2025-06-11 5:00 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 1,600 | $7.8 | 3,459,913 (Indirect) | View |
| 2025-06-10 Exercise | 2025-06-11 5:00 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund II L.P. Director 10% Owner | 12,500 | $12.31 | 3,459,913 (Indirect) | View |
| 2025-06-02 Option Award | 2025-06-03 4:30 pm | N/A 2035-06-01 | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Harwin Peter Evan Kiselak Tomas Director 10% Owner | 17,500 | $0 | 17,500 (Indirect) | View |
| 2025-05-29 Option Award | 2025-06-02 4:39 pm | N/A 2035-05-29 | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Harwin Peter Evan Kiselak Tomas Fairmount Healthcare Fund II L.P. Director | 50,000 | $0 | 50,000 (Indirect) | View |
| 2025-04-29 Option Award | 2025-05-01 6:16 pm | N/A 2035-04-29 | Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 23,017 | $0 | 23,017 (Direct) | View |
Ownership | 2025-05-01 5:58 pm | N/A N/A | Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 20,777,527 (Indirect) | View |
| 2024-11-19 Exercise | 2024-11-21 6:30 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 160,160 | $0 | 3,371,922 (Indirect) | View |
| 2024-09-27 Other | 2024-10-01 8:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director | 62,146 | $0 | 2,762,837 (Indirect) | View |
| 2024-09-12 Option Award(A) | 2024-09-17 8:56 pm | N/A 2034-09-11 | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 37,000 | $0 | 1,929,806 (Indirect) | View |
| 2024-09-16 Conversion(A) | 2024-09-17 8:56 pm | N/A N/A | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 12,635,428 | $0 | 1,929,806 (Indirect) | View |
| 2024-09-12 Option Award | 2024-09-16 8:54 pm | N/A 2034-09-11 | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 37,000 | $0 | 1,641,891 (Indirect) | View |
| 2024-09-16 Conversion | 2024-09-16 8:54 pm | N/A N/A | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 12,635,428 | $0 | 1,641,891 (Indirect) | View |
| 2024-09-11 Option Award | 2024-09-13 4:55 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 275,000 | $23 | 3,212,082 (Indirect) | View |
| 2024-09-11 Option Award | 2024-09-13 4:55 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 160 | $23,000 | 3,212,082 (Indirect) | View |
Ownership | 2024-09-12 9:41 pm | N/A N/A | Zenas BioPharma Inc. | ZBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 1,592,806 (Indirect) | View |
Ownership | 2024-09-06 5:07 pm | N/A N/A | Oruka Therapeutics Inc. | ORKA | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 0 | $0 | 19,662,752 (Indirect) | View |
| 2024-06-10 Exercise | 2024-06-12 9:01 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 1,501,500 | $0 | 6,225,641 (Indirect) | View |
| 2024-06-05 Option Award | 2024-06-07 8:00 pm | N/A 2034-06-05 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director | 20,740 | $0 | 20,740 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 7:57 pm | N/A 2034-05-22 | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director | 11,000 | $0 | 11,000 (Indirect) | View |
| 2024-05-14 Option Award | 2024-05-16 4:10 pm | N/A 2034-05-14 | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director | 22,646 | $0 | 22,646 (Indirect) | View |
| 2024-04-25 Exercise | 2024-04-25 4:55 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 3,730,672 | $0 | 5,176,222 (Indirect) | View |
| 2024-03-28 Other | 2024-04-01 6:32 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner | 49,857 | $0 | 1,990,722 (Indirect) | View |
| 2024-04-01 Other | 2024-04-01 6:21 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director | 58,857 | $0 | 2,880,551 (Indirect) | View |
| 2024-03-28 Other | 2024-04-01 6:19 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 310,679 | $0 | 5,366,757 (Indirect) | View |
| 2024-03-28 Other | 2024-04-01 5:44 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 498,765 | $0 | 9,006,126 (Indirect) | View |
| 2024-02-16 Option Award | 2024-02-16 6:43 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC 10% Owner | 1,500 | $7,500 | 4,727,141 (Indirect) | View |
| 2024-02-16 Option Award | 2024-02-16 6:43 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC 10% Owner | 1,166,666 | $7.5 | 4,727,141 (Indirect) | View |
| 2024-01-29 Other | 2024-01-31 4:31 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 943,695 | $0 | 1,046,027 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-24 7:02 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 832,333 | $12 | 3,595,170 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-24 7:02 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner | 834,334 | $12 | 3,595,170 (Indirect) | View |
| 2023-12-29 Other | 2023-12-29 5:00 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 3,841,518 | $0 | 5,485,719 (Indirect) | View |